Go Pro

Tyra Biosciences (TYRA) Earnings Date, Estimates & Call Transcripts

Tyra Biosciences logo
$24.94 -1.19 (-4.55%)
As of 08/28/2026 04:00 PM Eastern

Tyra Biosciences Earnings Summary

Tyra Biosciences issued Q2 2026 earnings on August 4, 2026, reporting an EPS of -$0.69, which missed analysts' consensus estimates of -$0.65 by $0.04. With a trailing EPS of -$2.40, Tyra Biosciences' earnings are expected to decrease next year, from ($2.74) to ($3.06) per share.

Upcoming Q3
Earnings Date
Nov. 4Before Market OpensEstimated
Consensus EPS
(Aug. 4)
-$0.65
Actual EPS
(Aug. 4)
-$0.69 Missed By -$0.04

Q2 2026 Earnings Resources

TYRA Upcoming Earnings

Tyra Biosciences' next earnings date is estimated for Wednesday, November 4, 2026, based on past reporting schedules.

Get Tyra Biosciences Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Tyra Biosciences and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

TYRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Tyra Biosciences Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$0.64-$0.61-$0.63
Q2 20262-$0.69-$0.57-$0.63
Q3 20262-$0.76-$0.60-$0.68
Q4 20262-$0.77-$0.65-$0.71
FY 2026 8 -$2.86 -$2.43 -$2.65
Q1 20271-$0.78-$0.78-$0.78
Q2 20271-$0.80-$0.80-$0.80
Q3 20271-$0.81-$0.81-$0.81
Q4 20271-$0.81-$0.81-$0.81

Tyra Biosciences Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/4/2026
(Estimated)
--------
8/4/2026Q2 2026-$0.6499-$0.69 -$0.0401-$0.69--
5/13/2026Q1 2026-$0.60-$0.64 -$0.04-$0.64--
3/2/2026Q4 2025-$0.54-$0.57 -$0.03-$0.57--
11/5/2025Q3 2025-$0.50-$0.50--$0.50--
8/14/2025Q2 2025-$0.53-$0.47+$0.06-$0.47--
5/8/2025Q1 2025-$0.49-$0.47+$0.02-$0.47--
3/27/2025Q4 2024-$0.48-$0.43+$0.05-$0.43--
11/7/2024--$0.40-$0.41 -$0.01-$0.41--

Tyra Biosciences Earnings - Frequently Asked Questions

Tyra Biosciences has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 4th, 2026 based off last year's report dates. Learn more on TYRA's earnings history.

In the previous quarter, Tyra Biosciences (NASDAQ:TYRA) missed the analysts' consensus estimate of ($0.65) by $0.04 with a reported earnings per share (EPS) of ($0.69). Learn more on analysts' earnings estimate vs. TYRA's actual earnings.

Tyra Biosciences (NASDAQ:TYRA) has a recorded net income of -$119.95 million. TYRA has generated -$2.40 earnings per share over the last four quarters.

Tyra Biosciences' earnings are expected to decrease from ($2.74) per share to ($3.06) per share in the next year.


Earnings data for NASDAQ:TYRA is sourced from Fiscal.ai, with the most recent quarter reported on 8/4/2026. New results are added as companies report their earnings.
From Our Partners